Roche raids Eli Lilly for its next chief medical officer as Sandra Horning plans to step down
We found out Monday morning where Levi Garraway was headed after he left Eli Lilly as head of oncology R&D a few days ago. Roche named Garraway as their new chief medical officer, replacing Sandra Horning, who they say is retiring from the company.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 59,400+ biopharma pros reading Endpoints daily — and it's free.